These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
☐
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2016
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report………………..
For the transition period from to
|
|
ISRAEL
|
|
(Jurisdiction of incorporation
or organization)
|
|
None
|
None
|
|
|
Title of each class
|
|
Name of each exchange on which registered
|
|
Ordinary Shares, NIS 0.01 nominal value per share
|
NASDAQ GLOBAL SELECT MARKET
|
|
Large accelerated filer ☐
|
|
Accelerated filer
☒
|
|
Non-accelerated filer ☐
|
|
|
7
|
|
|
|
7
|
|
|
|
7
|
|
|
7
|
||
|
A.
Selected Financial Data
|
7
|
|
|
B. Capitalization and indebtedness
|
12
|
|
|
C. Reason for the offer and use of proceeds
|
12
|
|
|
D. Risk Factors
|
12
|
|
|
28
|
||
|
A.
History and Development of the Company
|
28
|
|
|
B.
Business Overview
|
30
|
|
|
Principal Markets
|
33
|
|
|
Manufacturing and Suppliers
|
34
|
|
|
Marketing Channels
|
36
|
|
|
Patents and Licenses
|
38
|
|
|
Competition
|
39
|
|
|
Governmental Regulation Affecting the Company
|
40
|
|
|
C.
Organizational Structure
|
41
|
|
|
D.
Property, Plant and Equipment
|
41
|
|
|
|
43
|
|
|
43
|
||
|
Critical Accounting Policies
|
43
|
|
| A. Operating Results |
48
|
|
|
Impact of Inflation and Currency Fluctuations on Results of Operations, Liabilities and Assets
|
52
|
|
| B. Liquidity and Capital Resources |
53
|
|
| C. Research and development, patents and licenses, etc. |
54
|
|
| D. Trend Information |
56
|
|
| E. Off-Balance Sheet Arrangements |
57
|
|
|
F.
Tabular disclosure of contractual obligations
|
58
|
|
|
59
|
||
| A. Directors and Senior Management |
59
|
|
| B. Compensation |
62
|
|
| C. Board Practices |
65
|
|
|
Board of Directors
|
67
|
|
|
External Directors
|
67
|
|
|
Audit Committee
|
72
|
|
|
Compensation Committee
|
74
|
|
|
Internal Auditor
|
79
|
|
| D. Employees |
79
|
|
|
E.
Share Ownership
|
81
|
|
|
82
|
||
| A. Major Shareholders |
82
|
|
|
B.
Related Party Transactions
|
83
|
|
| ITEM 8. FINANCIAL INFORMATION | 86 | |
| A. Consolidated Statements and Other Financial Information | 86 | |
| B. Significant Changes | 88 | |
|
88
|
||
| A. Offer and listing details |
88
|
|
|
Markets and Share Price History
|
88
|
|
| ITEM 10. ADDITIONAL INFORMATION | 91 | |
| A. Share Capital | 91 | |
| B. Memorandum and Articles of Association | 91 | |
| C. Material Contracts | 101 | |
| D. Exchange Controls | 102 | |
| E. Taxation | 103 | |
| F. Dividends and Paying Agents | 119 | |
| G. Statement by experts | 119 | |
| H. Documents on Display | 119 | |
| I. Subsidiary Information | 120 | |
|
120
|
||
|
Interest Rate Risk
|
120
|
|
|
Foreign Currency Exchange Risk
|
121
|
|
|
|
122
|
|
|
|
122
|
|
|
|
122
|
|
|
|
122
|
|
|
123
|
||
|
Disclosure Controls and Procedures
|
123
|
|
|
Management's Annual Report on Internal Control over Financial Reporting
|
123
|
|
|
Inherent Limitations on Effectiveness of Controls
|
123
|
|
|
Changes in Internal Control over Financial Reporting
|
124
|
|
|
|
124
|
|
|
|
124
|
|
|
|
124
|
|
|
|
124
|
|
|
|
124
|
|
|
|
125
|
|
|
|
125
|
|
|
|
125
|
|
|
|
126
|
|
|
|
128
|
|
|
|
128
|
|
|
|
128
|
|
|
|
128
|
|
|
128
|
||
|
2012
|
2013
|
2014
|
2015
|
2016
|
||||||||||||||||
|
Sales
|
$
|
48,729
|
$
|
73,298
|
$
|
75,622
|
$
|
82,738
|
$
|
100,347
|
||||||||||
|
Cost of sales
|
28,849
|
43,865
|
44,835
|
48,659
|
61,796
|
|||||||||||||||
|
Gross profit
|
19,880
|
29,433
|
30,787
|
16.
34,079
|
38,551
|
|||||||||||||||
|
Research and development costs
|
4,401
|
5,465
|
6,480
|
9,702
|
12,663
|
|||||||||||||||
|
Sales and marketing expenses
|
3,081
|
3,818
|
4,418
|
5,651
|
6,423
|
|||||||||||||||
|
General and administrative expenses
|
2,369
|
2,572
|
2,798
|
3,611
|
3,969
|
|||||||||||||||
|
Contingent consideration expense (benefit)
|
0
|
0
|
45
|
(3,090
|
)
|
(334
|
)
|
|||||||||||||
|
Total operating expenses
|
9,851
|
11,855
|
13,741
|
15,874
|
22,721
|
|||||||||||||||
|
Operating income
|
10,029
|
17,578
|
17,046
|
18,205
|
15,830
|
|||||||||||||||
|
Financial income, net
|
752
|
404
|
263
|
220
|
35
|
|||||||||||||||
|
Income before income taxes
|
10,781
|
17,982
|
17,309
|
18,425
|
15,865
|
|||||||||||||||
|
Income tax expenses
|
910
|
905
|
2,704
|
1,905
|
2,728
|
|||||||||||||||
|
Net income
(1)
|
9,871
|
17,077
|
14,605
|
16,520
|
13,137
|
|||||||||||||||
|
Net income per share
|
||||||||||||||||||||
|
Basic income per ordinary share
|
$
|
1.424
|
$
|
2.404
|
$
|
2.033
|
$
|
2.273
|
$
|
1.789
|
||||||||||
|
Diluted income per ordinary share
|
$
|
1.417
|
$
|
2.357
|
$
|
1.996
|
$
|
2.242
|
$
|
1.767
|
||||||||||
|
Weighted average number of ordinary shares used to compute basic income per share (in thousands)
|
6,934
|
7,103
|
7,184
|
7,269
|
7,344
|
|||||||||||||||
|
Weighted average number of ordinary shares used to compute diluted income per share (in thousands)
|
6,968
|
7,246
|
7,319
|
7,368
|
7,435
|
|||||||||||||||
|
2012
|
2013
|
2014
|
2015
|
2016
|
||||||||||||||||
|
Total assets
|
$
|
89,033
|
$
|
105,257
|
$
|
122,436
|
$
|
139,998
|
$
|
146,437
|
||||||||||
|
Total current liabilities
|
$
|
11,789
|
$
|
11,948
|
$
|
19,006
|
$
|
19,814
|
$
|
17,964
|
||||||||||
|
Long-term liability
|
$
|
2,278
|
$
|
2,618
|
$
|
2,698
|
$
|
7,350
|
$
|
7,081
|
||||||||||
|
Shareholders' equity
|
$
|
74,966
|
$
|
90,691
|
$
|
100,732
|
$
|
112,834
|
$
|
121,392
|
||||||||||
|
Capital stock
|
$
|
21
|
$
|
21
|
$
|
21
|
$
|
21
|
$
|
22
|
||||||||||
|
Number of ordinary shares issued
(1)
|
|
|
7,233,604
|
7,299,315
|
7,396,584
|
|||||||||||||||
|
NIS per U.S. $
|
||||||||||||||||
|
Year Ended December 31,
|
High
|
Low
|
Average
|
Period End
|
||||||||||||
|
2016
|
3.983
|
3.746
|
3.841
|
3.845
|
||||||||||||
|
2015
|
4.053
|
3.761
|
3.887
|
3.902
|
||||||||||||
|
2014
|
3.994
|
3.402
|
3.577
|
3.889
|
||||||||||||
|
2013
|
3.728
|
3.471
|
3.601
|
3.471
|
||||||||||||
|
2012
|
4.028
|
3.715
|
3.844
|
3.733
|
||||||||||||
|
|
NIS per U.S. $ | |||||||||||||||
|
Month
|
High
|
Low
|
Average
|
Period End
|
||||||||||||
|
March 2017
|
3.693
|
3.614
|
3.649
|
3.623
|
||||||||||||
|
February 2017
|
3.768
|
3.707
|
3.740
|
3.710
|
||||||||||||
|
January 2017
|
3.860
|
3.769
|
3.818
|
3.769
|
||||||||||||
|
December 2016
|
3.867
|
3.787
|
3.829
|
3.845
|
||||||||||||
|
November 2016
|
3.876
|
3.799
|
3.843
|
3.839
|
||||||||||||
|
October 2016
|
3.856
|
3.778
|
3.821
|
3.811
|
||||||||||||
| · |
Substantial research and development and business development expenditures, which could divert funds from other corporate uses and/or have a significant negative effect on our short-term results;
|
| · |
Diversion of management’s attention from our core business; and
|
| · |
Entering markets in which we have little or no experience.
|
| · |
Post-merger integration problems resulting from the combination of any acquired operations with our own operations or from the combination of two or more operations into a new merged entity;
|
| · |
Diversion of management’s attention from our core business;
|
| · |
Substantial expenditures, which could divert funds from other corporate uses;
|
| · |
Entering markets in which we have little or no experience; and
|
| · |
Loss of key employees of the acquired operations.
|
| (i) |
Server network interface cards with and without bypass (Server Adapters);
|
| (ii) |
Intelligent and programmable cards, with features such as encryption, acceleration, data compression, redirection, time stamping, network capture solutions, SD-WAN (Software-Defined Wide Area Network), FPGA based ultra-low latency solutions, other offload features and/or compute blades (Smart Cards); and
|
| (iii) |
Stand-alone Products (including Bypass Switches, Intelligent Bypass Switches, the patented SETAC (Server To Appliance Converter) product family and the CPE/Edge/Low End Appliance Units.
|
| (i) |
Network appliances, including WAN Optimization and SD-WAN, Internet Security, Cyber Security, Application Delivery, Traffic Management, Network Monitoring and Analytics, High Frequency Trading (HFT) for the financial service market and other mission-critical sectors;
|
| (ii) |
Servers;
|
| (iii) |
Data storage including Big Data;
|
| (iv) |
The "Cloud" (virtualized data centers with and without SDN);
|
| (v) |
Network CPE/EDGE/Low End appliances; and
|
| (vi) |
IOT.
|
| · |
We approach a potential customer or are approached by such customer.
|
| · |
If the customer shows interest in the products and we believe that achievement of a business relationship with the customer is possible, we ship products for such customer’s evaluation.
|
| · |
During the evaluation process the customer receives a few units of the relevant product for initial basic testing. If the evaluation process is successful, we ship products for qualification.
|
| · |
During the qualification process the customer receives a larger amount of our products for more specific testing, which may include certain adaptations of our products to its specific needs.
|
| · |
If the qualification process is successful, we enter into negotiations regarding the terms of a business relationship.
|
| · |
In some cases, typically with the larger customers, the evaluation and qualification process may take 12 months or more.
|
| · |
Silicom Connectivity Solutions, Inc. – a private company incorporated in the United States; and
|
| · |
Silicom Denmark A/S (Fiberblaze A/S) – a private company incorporated in Denmark. On December 10, 2014, we entered into the Fiberblaze SPA for the purchase of the entire holdings in Fiberblaze, pursuant to which we became its sole shareholder. As part of the Fiberblaze SPA, we have also purchased Fiberblaze US LLC, a private company incorporated in the United States, being a 100% owned subsidiary of Fiberblaze. In October 2016 we commenced a voluntary liquidation process for the liquidation of Fiberblaze US LLC. As of the date of this report, the voluntary liquidation is still pending. In 2017 we changed the name of the company from Fiberblaze A/S to the company's current name – Silicom Denmark A/S (Fiberblaze A/S) and all the rights related to the company’s previous name remained ours. See "Item 10 – Additional Information – C. "Material Contracts" for additional information on the Fiberblaze SPA.
|
| · |
Goodwill and other intangible assets - Goodwill reflects the excess of the purchase price of business acquired over the fair value of net assets acquired. Goodwill is not amortized but instead is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying value may be impaired.
|
| · |
Inventories – Inventories are stated at the lower of cost or market. Cost is determined using the "weighted average-cost" method. We write down obsolete or slow moving inventory to its market value.
|
| · |
Marketable securities – We account for investments which we intend and are able to hold to maturity, that are classified as held-to-maturity investments as defined in ASC 320-10, "Accounting for Certain Investments in Debt and Equity Securities".
|
| · |
Income Taxes – We account for income taxes under ASC 740-10, "Accounting for Income taxes". Under ASC 740-10, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred taxes assets to the amount expected to be realized. Valuation allowances in respect of deferred taxes were recorded in respect of the following matter:
|
| § |
Deferred tax assets that, as we believe, are more likely than not to be realized. In assessing the potential of realization of deferred tax assets, we consider projected future taxable income and tax planning strategies.
|
| · |
Accounting for Stock-Based Compensation – The Company recognizes compensation expense in accordance with ASC topic 718, "Compensation – stock compensation" based on estimated grant date fair value using an option-pricing model. For our option grants granted after January 1, 2008 which include features that are not supported by the Black and Scholes valuation model, such as expiration of said awards if the closing price of our shares falls below 50% of the respective awards' exercise price, we recognize compensation expense based on estimated grant date fair value using the Monte Carlo option-pricing model or the Binomial option-pricing model. Where our option awards granted after January 1, 2008 do not include features that are not supported by the Black and Scholes valuation model, we recognize compensation expense based on estimated grant date fair value using the Black and Scholes model. For our RSU grants, we recognize compensation expenses based on the market value of our shares on the date of grant, less an estimate of dividends that will not accrue to RSU holders prior to vesting.
|
| · |
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The standard can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We have not yet selected a transition method and we are evaluating the impact of adopting the standard on our ongoing financial reporting. Based on our assessment as of the date of these financial statements, the impact of adopting the new standard is not expected to be material.
|
| · |
In July 2015, the FASB issued ASU 2015-11, which, for entities that do not measure inventory using the last-in, first-out (LIFO) or retail inventory method, changes the measurement principle for inventory from the lower of cost or market to lower of cost and net realizable value. The ASU also eliminates the requirement for these entities to consider replacement cost or net realizable value less an approximately normal profit margin when measuring inventory. This ASU is effective in fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. This ASU is to be applied prospectively. Early adoption is permitted as of the beginning of an interim or annual period.
|
| · |
In November 2015, the FASB issued ASU 2015-17, which requires entities with a classified balance sheet to present all deferred tax assets and liabilities as noncurrent. This ASU is effective for interim and annual periods in fiscal years beginning after December 15, 2016. Early adoption is permitted.
|
| · |
In February 2016, the FASB issued ASU 2016-02, which requires lessees to recognize most of their leases on balance sheet as a right-of-use asset and a lease liability. This ASU is effective for interim and annual periods in fiscal years beginning after December 15, 2018. Early adoption is permitted.
|
| · |
On March 30, 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting, which is intended to improve the accounting for share-based payment transactions as part of the FASB’s simplification initiative. This ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2016. Early adoption is permitted in any interim or annual period provided that the entire ASU is adopted.
|
| · |
In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, which significantly changes the way entities recognize impairment of many financial assets by requiring immediate recognition of estimated credit losses expected to occur over their remaining life. This ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2019. Early adoption is permitted for annual and interim periods in fiscal years beginning after December 15, 2018.
|
|
2014
|
2015
|
2016
|
||||||||||
|
Sales
|
100
|
%
|
100
|
%
|
100
|
%
|
||||||
|
Cost of sales
|
59.3
|
58.8
|
61.6
|
|||||||||
|
Gross profit
|
40.7
|
41.2
|
38.4
|
|||||||||
|
Research and development costs
|
8.6
|
11.7
|
12.6
|
|||||||||
|
Sales and marketing expenses
|
5.8
|
6.8
|
6.4
|
|||||||||
|
General and administrative expenses
|
3.7
|
4.4
|
3.9
|
|||||||||
|
Contingent consideration expense (benefit)
|
0.1
|
(3.7
|
)
|
(0.3
|
)
|
|||||||
|
Operating Income
|
22.5
|
22.0
|
15.8
|
|||||||||
|
Financial income, net
|
0.4
|
0.3
|
-
|
|||||||||
|
Income before income taxes
|
22.9
|
22.3
|
15.8
|
|||||||||
|
Income tax expenses
|
3.6
|
2.3
|
2.7
|
|||||||||
|
Net Income
|
19.3
|
20.0
|
13.1
|
|||||||||
|
Contractual Obligations
|
Payments due by period
|
||||
|
Total
|
Less than 1 year
|
1-3 years
|
3-5 years
|
More than 5 years
|
|
|
Operating Leases
|
$3,780
|
$1,481
|
$2,135
|
$164
|
|
|
Purchase Obligations
|
$14,190
|
$14,190
|
|||
|
Total
|
$17,970
|
$15,671
|
$2,135
|
$164
|
|
|
Name
|
Age
|
Position with Company
|
|
Avi Eizenman
(1)
|
59
|
Active Chairman of the Board
|
|
Shaike Orbach
(2)
|
65
|
President, Chief Executive Officer, Director
|
|
Ayelet Aya Hayak
(3)
|
47
|
External Director
|
|
Ilan Erez
(3)
|
49
|
External Director
|
|
Eli Doron
(4)
|
64
|
Director
|
|
Eran Gilad
|
49
|
Chief Financial Officer and Company Secretary
|
| (1) |
Was re-elected for an additional three-year term, commencing as of June 8, 2016.
|
| (2) |
Was re-elected for an additional one-year term, commencing as of June 8, 2016.
|
| (3) |
Was re-elected for an additional three-year term, commencing as of June 8, 2016.
|
| (4) |
Was re-elected for an additional two-year term, commencing as of June 8, 2016.
|
|
Name and
Position
|
Salary and
Benefits(1)
|
Cash Bonus(2)
|
Equity-based Compensation(3)
|
Total
|
||||||||||||
|
Avi Eizenman – Active Chairman
|
553,563
|
263,246
|
389,883
|
1,206,692
|
||||||||||||
|
Yeshayahu ('Shaike') Orbach – CEO and President
|
351,707
|
263,246
|
389,883
|
1,004,836
|
||||||||||||
|
David Hendel – VP Research and Development
|
221,493
|
30,489
|
71,793
|
323,775
|
||||||||||||
|
Elad Blatt – VP Business Development and Sales North America
|
183,196
|
61,198
|
71,793
|
316,187
|
||||||||||||
|
David Castiel – VP Engineering
|
208,127
|
30,489
|
71,793
|
310,409
|
||||||||||||
| (1) |
"
Salary and Benefits
" include annual salary or service fees paid, payments to the National Insurance Institute, manager's insurance and pension funds, severance, advanced education funds, basic health insurance, vacation pay, recuperation pay, tax gross-up payments, automobile-related expenses, telephone expenses and benefits and perquisites as mandated by Israeli or applicable law.
|
| (2) |
"
Cash Bonus
" includes bonus payments as recorded in our financial statements for the year ended December 31, 2016.
|
| (3) |
"
Equity-based Compensation
" includes the expense recorded in our financial statements for the year ended December 31, 2016 with respect to equity-based compensation granted to the executive offices detailed above.
|
| · |
An employment relationship;
|
| · |
A business or professional relationship maintained on a regular basis;
|
| · |
Control; and
|
| · |
Service as an office holder.
|
| · |
the majority includes at least a majority of the shares held by non-controlling and disinterested shareholders who are present and voting at the meeting; or
|
| · |
the total number of shares held by non-controlling and disinterested shareholders that voted against the election of the director does not exceed two percent of the aggregate voting rights in the company.
|
| · |
The chairman of the board of directors;
|
| · |
Any director employed by or otherwise providing services to the company or to the "controlling shareholder" or entity under such controlling shareholder's control;
|
| · |
Any director who derives his salary primarily from a controlling shareholder;
|
| · |
A "controlling shareholder"; or
|
| · |
Any relative of a "controlling shareholder".
|
| · |
The chairman of the board of directors;
|
| · |
Any director employed by or otherwise providing services to the company or to the controlling shareholder or entity under such controlling shareholder's control;
|
| · |
Any director who derives his salary primarily from a "controlling shareholder";
|
| · |
A "controlling shareholder"; or,
|
| · |
Any relative of a "controlling shareholder".
|
| 1. |
To recommend to the Board of Directors as to a compensation policy for officers of the company, as well as to recommend, once every three years to extend the compensation policy subject to receipt of the required corporate approvals;
|
| 2. |
To recommend to the Board of Directors as to any updates to the compensation policy which may be required;
|
| 3. |
To review the implementation of the compensation policy by the company;
|
| 4. |
To approve transactions relating to terms of office and employment of certain company office holders, which require the approval of the compensation committee pursuant to the Companies Law; and
|
| 5. |
To exempt, under certain circumstances, a transaction relating to terms of office and employment from the requirement of approval of the shareholders meeting.
|
| a. |
Advancement of the goals of the company, its working plan and its long term policy;
|
| b. |
The creation of proper incentives for the office holders while taking into consideration, inter alia, the company’s risk management policies;
|
| c. |
The company’s size and nature of its operations;
|
| d. |
The contributions of the relevant office holders in achieving the goals of the company and profit in the long term in light of their positions;
|
| e. |
The education, skills, expertise and achievements of the relevant office holders;
|
| f. |
The role of the office holders, areas of their responsibilities and previous agreements with them;
|
| g. |
The correlation of the proposed compensation with the compensation of other employees of the company, and the effect of such differences in compensation on the employment relations in the company; and
|
| h. |
The long term performance of the office holder.
|
| (i) |
The majority of the votes includes at least a majority of all the votes of shareholders who are not controlling shareholders of the company or who do not have a personal interest in the compensation policy and participating in the vote; abstentions shall not be included in the total of the votes of the aforesaid shareholders; or
|
| (ii) |
The total of opposing votes from among the shareholders described in subsection (i) above does not exceed 2% of all the voting rights in the company
.
|
|
As of December 31
|
2014
|
2015
|
2016
|
|||||||||
|
Total Employees
|
197
|
238
|
240
|
|||||||||
|
Marketing, Sales, Customer Services
|
22
|
26
|
24
|
|||||||||
|
Research & Development
|
66
|
81
|
79
|
|||||||||
|
Manufacturing
|
97
|
114
|
121
|
|||||||||
|
Corporate Operations and Administration
|
12
|
17
|
16
|
|||||||||
|
Name and Address
|
Number of Shares and Options Owned
1
|
Percent of Outstanding Shares
|
||||||
|
Avi Eizenmann
|
247,618
|
3.34
|
%
|
|||||
|
Shaike Orbach
|
12,500
|
*
|
||||||
|
Eli Doron
|
*
|
*
|
||||||
|
Ayelet Aya Hayak
|
*
|
*
|
||||||
|
Ilan Erez
|
*
|
*
|
||||||
|
Eran Gilad
|
*
|
*
|
||||||
|
All directors and officers as a group
|
260,118
|
3.51
|
%
|
|||||
|
Name of Shareholder
|
Number of Shares and Options Owned
1
|
Percentage of Outstanding Shares
|
||||||
|
Zohar Zisapel
2
|
1,511,722
|
20.48
|
%
|
|||||
|
Dov Yelin/Yair Lapidot/Yelin Lapidot Holdings Management Ltd.
3
|
440,171
|
5.96
|
%
|
|||||
|
Harel Insurance Investments & Financial Services Ltd
.
4
|
221,113
|
3.00
|
%
|
|||||
|
PERIOD
|
LOW
|
HIGH
|
||||||
|
LAST 6 CALENDAR MONTHS
|
||||||||
|
March 2017
|
37.35
|
50.00
|
||||||
|
February 2017
|
35.02
|
39.01
|
||||||
|
January 2017
|
34.86
|
41.50
|
||||||
|
December 2016
|
37.60
|
41.11
|
||||||
|
November 2016
|
34.46
|
41.20
|
||||||
|
October 2016
|
34.89
|
42.69
|
||||||
|
FINANCIAL QUARTERS DURING THE PAST TWO YEARS
|
||||||||
|
First Quarter 2017
|
34.86
|
50.00
|
||||||
|
Fourth Quarter 2016
|
34.46
|
42.69
|
||||||
|
Third Quarter 2016
|
27.06
|
44.00
|
||||||
|
Second Quarter 2016
|
25.48
|
34.35
|
||||||
|
First Quarter 2016
|
26.15
|
34.20
|
||||||
|
Fourth Quarter 2015
|
25.00
|
33.96
|
||||||
|
Third Quarter 2015
|
24.86
|
37.24
|
||||||
|
Second Quarter 2015
|
34.80
|
44.54
|
||||||
|
FIVE MOST RECENT FULL FINANCIAL YEARS
|
||||||||
|
2016
|
25.48
|
44.00
|
||||||
|
2015
|
24.86
|
48.43
|
||||||
|
2014
|
26.00
|
73.44
|
||||||
|
2013
|
17.97
|
46.15
|
||||||
|
2012
|
13.11
|
20.33
|
||||||
|
PERIOD
|
LOW
|
HIGH
|
||||||
|
FINANCIAL QUARTERS DURING THE PAST TWO YEARS
|
||||||||
|
First Quarter 2016
1
|
125.00
|
169.00
|
||||||
|
Fourth Quarter 2015
|
97.08
|
131.10
|
||||||
|
Third Quarter 2015
|
96.01
|
141.60
|
||||||
|
Second Quarter 2015
|
134.90
|
178.30
|
||||||
|
First Quarter 2015
|
125
|
189.60
|
||||||
|
FIVE MOST RECENT FULL FINANCIAL YEARS
|
||||||||
|
2015
|
96.01
|
189.60
|
||||||
|
2014
|
89.74
|
257.20
|
||||||
|
2013
|
66.50
|
166.60
|
||||||
|
2012
|
51.60
|
73.00
|
||||||
|
2011
|
44.16
|
80.64
|
||||||
| · |
Appointment or termination of our auditors;
|
| · |
Appointment and dismissal of external directors, unless the company elects to opt-in to the exemptions promulgated under the Amendment to the Relief Regulations as detailed above, under which there is no requirement to appoint external directors;
|
| · |
Approval of interested party acts and transactions requiring general meeting approval as provided in sections 255 and 268 to 275 of the Israeli Companies Law;
|
| · |
A merger as provided in section 320(a) of the Israeli Companies Law;
|
| · |
The exercise of the powers of the board of directors, if the board of directors is unable to exercise its powers and the exercise of any of its powers is vital for our proper management, as provided in section 52(a) of the Israeli Companies Law;
|
| · |
Amendments to our Articles;
and
|
| · |
Approval of an increase or decrease of the registered share capital.
|
| · |
All of the directors are permitted to vote on the matter and attend the meeting in which the matter is considered; and
|
| · |
The matter requires approval of the shareholders at a general meeting.
|
| 1. |
A private placement that meets all of the following conditions:
|
| · |
The private placement will increase the relative holdings of a shareholder that holds five percent or more of the company’s outstanding share capital, assuming the exercise of all of the securities convertible into shares held by that person, or that will cause any person to become, as a result of the issuance, a holder of more than five percent of the company's outstanding share capital.
|
| · |
20 percent or more of the voting rights in the company prior to such issuance are being offered.
|
| · |
All or part of the consideration for the offering is not cash or registered securities, or the private placement is not being offered at market terms.
|
| 2. |
A private placement which results in anyone becoming a "controlling shareholder" of the public company.
|
| · |
Any amendment to the articles of association;
|
| · |
An increase of the company’s authorized share capital;
|
| · |
A merger; or
|
| · |
Approval of interested party acts and transactions that require general meeting approval as provided in sections 255 and 268 to 275 of the Israeli Companies Law.
|
| · |
Code of Corporate Governance.
Under the Sixteenth Amendment, a code of recommended corporate governance practices has been attached as an annex to the Companies Law. In the explanatory notes to the legislation, the Knesset noted that an "adopt or disclose non-adoption" regulation would be issued by the
ISA
with respect to such code. As of the date of this Annual Report, the
ISA
has issued reporting instructions with respect to this code which are applicable only to publicly traded companies whose securities are traded solely on the Tel Aviv Stock Exchange and which report solely to the
ISA
.
|
| · |
Fines.
The
ISA
shall be authorized to impose fines on any person or company performing a violation, in connection with a publicly traded company which reports to the
ISA
, and specifically designated as a violation under the Sixteenth Amendment.
|
| · |
Distribution of annual and quarterly reports to shareholders
– Under Israeli law we are not required to distribute annual and quarterly reports directly to shareholders and the generally accepted business practice in Israel is not to distribute such reports to shareholders. We do however make our audited financial statements available to our shareholders prior to our annual general meeting and furnish our quarterly and annual financial results with the SEC on Form 6-K.
|
| · |
Independence, Nomination and Compensation of Directors
– A majority of our Board of Directors may not necessarily be comprised of independent directors as defined in NASDAQ Listing Rule 5605(a)(2). Our Board of Directors contains two external directors in accordance with the provisions of the Companies Law. Israeli law does not require, nor do our external directors conduct, regularly scheduled meetings at which only they are present. In addition, with the exception of our external directors, our directors are elected to our Board of Directors in accordance with the new directors voting mechanism approved by our shareholders on the Annual General Meeting which took place on June 8, 2016. According to said directors voting mechanism, directors are divided into three groups, Group A, Group B and Group C. Each group is brought for re-election once every three years, on a rotating basis, such that at each annual general meeting of the shareholders a given group of directors is brought for election, to serve on a continuous basis for a three-year term, until the third annual general meeting following the meeting on which such group was elected for service and until their respective successors are duly elected, at which point their term in office shall expire. At each annual general meeting, the annual general meeting shall be entitled to elect directors to replace the directors whose three-year term in office has expired, and so on ad infinitum, so that each year, the term in office of one group of directors shall expire. The nominations for director which are presented to our shareholders are generally made by our board of directors. One or more shareholders of a company holding at least one percent of the voting power of the company may nominate a currently serving external director for an additional three year term. Israeli law does not require the adoption of, and our board has not adopted, a formal written charter or board resolution addressing the nomination process and related matters. Compensation of our directors and other officers of the Company is determined in accordance with Israeli law.
|
| · |
Audit Committee
– Our Audit Committee does not meet with all the requirements of NASDAQ Listing Rule 5605. We are of the opinion that the members of our Audit Committee comply with the requirements of NASDAQ Listing Rule 5605(c)(3) and Rule 10A-3(b) of the general rules and regulations promulgated under the Securities Act of 1933 and all requirements under Israeli law. Our Audit Committee has not adopted a formal written audit committee charter specifying the items enumerated in NASDAQ Listing Rule 5605(c)(1).
|
| · |
Compensation Committee
-
We follow the provisions of the Companies Law with respect to matters in connection with the composition and responsibilities of our Compensation Committee, office holder compensation, and any required approval by the shareholders of such compensation. Israeli law, and our amended and restated Articles, do not require that a compensation committee composed solely of independent members of our board of directors determine (or recommend to the board of directors for determination) an executive officer’s compensation, as required under NASDAQ’s listing standards related to compensation committee independence and responsibilities; nor do they require that the Company adopt and file a compensation committee charter. Instead, our compensation committee has been established and conducts itself in accordance with provisions governing the composition of and the responsibilities of a compensation committee as set forth in the Companies Law. Furthermore, the compensation of office holders is determined and approved by our Compensation Committee and our board of directors, and in certain circumstances by our shareholders, either in consistency with our previously approved Executive Compensation Policy or, in special circumstances in deviation therefrom, taking into account certain considerations set forth in the Companies Law. The requirements for shareholder approval of any office holder compensation, and the relevant majority or special majority for such approval, are all as set forth in the Companies Law. Thus, we will seek shareholder approval for all corporate actions with respect to office holder compensation requiring such approval under the requirements of the Companies Law, including seeking prior approval of the shareholders for the Executive Compensation Policy and for certain office holder compensation, rather than seeking approval for such corporate actions in accordance with NASDAQ Listing Rules.
|
| · |
Quorum
– Under Israeli law a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our Articles provide that a quorum of two or more shareholders, present in person or by proxy, holding shares conferring in the aggregate more than thirty three and a third (33 1/3 %) percent of the voting power of the Company is required for commencement of business at a general meeting.
|
| · |
Approval of Related Party Transactions
– All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transactions, set forth in sections 268 to 275 of the Companies Law.
|
| · |
Shareholder Approval
– We seek shareholder approval for all corporate action requiring such approval, in accordance with the requirements of the Companies Law.
|
| · |
Equity Compensation Plans
– We do not necessarily seek shareholder approval for the establishment of, and amendments to, stock option or equity compensation plans (as set forth in NASDAQ Listing Rule 5635(c)), as such matters are not subject to shareholder approval under Israeli law. We will attempt to seek shareholder approval for our stock option or equity compensation plans (and the relevant annexes thereto) to the extent required in order to ensure they are tax qualified for our employees in the United States. However, even if such approval is not received, then the stock option or equity compensation plans will continue to be in effect, but the Company will be unable to grant options to its U.S. employees that qualify as Incentive Stock Options for U.S. federal tax purpose. Our stock option or other equity compensation plans are also available to our non-U.S. employees, and provide features necessary to comply with applicable non-U.S. tax laws.
|
| · |
Replacement of all future tax incentives under the existing law as amended by the First Amendment; as a result, commencing 2011, industrial companies that meet the conditions set out by the Second Amendment will no longer be entitled to the existing tax incentives provided under the First Amendment, such as the exemption from tax on undistributed profits and a reduced tax rate thereafter, but rather to the tax incentives under the Second Amendment;
|
| · |
Under the transition provisions, any tax benefits obtained prior to 2011 shall continue to apply until expired, unless the company elects to apply the provisions of the Second Amendment to its income
; and
|
| · |
Pursuant to the second Amendment, a "Preferred Enterprise" is entitled to a reduced corporate flat tax rate of 15% with respect to its preferred income derived by its "Preferred Enterprise" in 2011-2012, unless the "Preferred Enterprise" is located in a certain development zone, in which case the rate will be 10%. Such corporate tax rates are 12.5% and 7% with respect to 2013,16% and 9% with respect to 2014, 16% and 9% with respect to 2015-2016 and 16% and 7.5% with respect to 2017 and thereafter. Income derived by a Preferred Company from a ‘Special Preferred Enterprise’ (as such term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or to 5% if the "Special Preferred Enterprise" is located in a certain development zone. Under the Second Amendment, the tax incentives offered by the Investment Law are no longer dependent neither on minimum qualified investments nor on foreign ownership
.
Companies will be able to enjoy both government grants and tax benefits concurrently. Governmental grants will not necessarily be dependent on the extent of enterprise’s investment in assets and/or equipment. Commencing 2011, the approval of "Preferred Enterprise" status by either the Israeli Tax Authorities or the appointed authority will be accepted by the other. Therefore a "Preferred Enterprise" will be eligible to receive both tax incentives and government grants, under certain conditions.
|
|
Source
|
% of
Dividend
|
Individual
Tax %
|
Corporations
Tax %
|
Foreign
Resident
Tax %
|
||||||||||||
|
|
Dividend Distributed on April 17, 2013
|
|||||||||||||||
|
Regular Income
|
34.6031
|
25
|
0
|
25
|
||||||||||||
|
Benefited Enterprise
|
65.3969
|
15
|
15
|
15
|
||||||||||||
|
|
Dividend Distributed on April 17, 2014
|
|||||||||||||||
|
Regular Income
|
52.9928
|
25
|
0
|
25
|
||||||||||||
|
Benefited Enterprise
|
47.0071
|
15
|
15
|
15
|
||||||||||||
|
Dividend Distributed on April 21, 2015
|
||||||||||||||||
|
Regular Income
|
5.5888
|
25
|
0
|
25
|
||||||||||||
|
Benefited Enterprise
|
12.7771
|
15
|
0
|
15
|
||||||||||||
|
Preferred Enterprise
|
81.6341
|
20
|
0
|
20
|
||||||||||||
|
Dividend Distributed on April 14, 2016
|
||||||||||||||||
|
Regular Income
|
0
|
25
|
0
|
25
|
||||||||||||
|
Preferred Enterprise
|
100.0000
|
20
|
0
|
20
|
||||||||||||
|
|
Dividend Distributed on April 5, 2017
|
|||||||||||||||
|
Regular Income
|
0
|
25
|
0
|
25
|
||||||||||||
|
Preferred Enterprise
|
100.0000
|
20
|
0
|
20
|
||||||||||||
|
2016
|
2015
|
|||||||
|
Audit Fees(1)
|
$
|
120,000
|
$
|
110,000
|
||||
|
Audit-Related Fees(2)
|
--
|
$
|
22,000
|
|||||
|
Tax Fees(3)
|
$
|
55,000
|
$
|
37,500
|
||||
| · |
We are not required to distribute annual and quarterly reports directly to shareholders, but we do make our audited financial statements available to our shareholders prior to our annual general meeting and furnish our quarterly and annual financial results with the SEC on Form 6-K;
|
| · |
A majority of our Board of Directors may not necessarily be comprised of independent directors as defined in the NASDAQ Listing Rules, but our Board of Directors contains two external directors in accordance with the Companies Law. Israeli law does not require, nor do our external directors conduct, regularly scheduled meetings at which only they are present. In addition, with the exception of our external directors, our directors are elected for terms of one year or until the following annual meeting, by a general meeting of our shareholders. The nominations for director which are presented to our shareholders are also generally made by our Board of Directors. Pursuant to the Companies Law, one or more shareholders of a company holding at least one percent of the voting power of the company may nominate a currently serving external director for an additional three year term. Israeli law does not require the adoption of and our board has not adopted a formal written charter or board resolution addressing the nomination process and related matters. Compensation of our directors and other officers of the Company is determined in accordance with Israeli Law;
|
| · |
Our Audit Committee has not adopted a formal written audit committee charter specifying the items enumerated in NASDAQ Listing Rule 5605(c)(1). We believe that the members of our audit committee comply with the requirements of the Israeli law, as well as NASDAQ Listing Rule 5605(c)(3) and Rule 10A-3(b) of the general rules and regulations promulgated under the Securities Act of 1933. For a detailed discussion please refer to "Item 6 – Directors, Senior Management and Employees – Audit Committee";
|
| · |
As opposed to NASDAQ Listing Rule 5620(c)(3), which sets forth a minimum quorum for a shareholders meeting, under Israeli law a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our current Articles provide that a quorum of two or more shareholders, present in person or by proxy, holding shares conferring in the aggregate more than thirty three and a third (33 1/3 %) percent of the voting power of the Company is required;
|
| · |
All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transactions set forth in the Companies Law, and are not subject to the review process set forth in NASDAQ Listing Rule 5630. For a detailed discussion please refer to "Item 10 – Additional Information – the Companies Law";
|
| · |
We seek shareholder approval for all corporate action requiring such approval in accordance with the requirements of the Companies Law rather than under the requirements of the NASDAQ Marketplace Rules, including (but not limited to) the appointment or termination of auditors, appointment and dismissal of directors, approval of interested party acts and transactions requiring general meeting approval as discussed above and a merger;
|
| · |
We follow the provisions of the Companies Law with respect to matters in connection with the composition and responsibilities of our compensation committee, office holder compensation, and any required approval by the shareholders of such compensation. Israeli law, and our amended and restated Articles, do not require that a compensation committee composed solely of independent members of our Board of Directors determine (or recommend to the board of directors for determination) an executive officer’s compensation, as required under NASDAQ listing standards related to compensation committee independence and responsibilities; nor do they require that the Company adopt and file a compensation committee charter. Instead, our Compensation Committee has been established and conducts itself in accordance with provisions governing the composition of and the responsibilities of a compensation committee as set forth in the Companies Law. Furthermore, the compensation of office holders is determined and approved by our Compensation Committee and our Board of Directors, and in certain circumstances by our shareholders, either in consistency with our previously approved Executive Compensation Policy or, in special circumstances in deviation therefrom, taking into account certain considerations set forth in the Companies Law. The requirements for approval by the shareholders for any office holder compensation, and the relevant majority or special majority for such approval, are all as set forth in the Companies Law. Thus, we will seek shareholder approval for all corporate actions with respect to office holder compensation requiring such approval under the requirements of the Companies Law, including seeking prior approval of the shareholders for the Executive Compensation Policy and for certain office holder compensation, rather than seeking approval for such corporate actions in accordance with NASDAQ Listing Rules; and
|
| · |
We do not necessarily seek shareholder approval for the establishment of, and amendments to, stock option or equity compensation plans (as set forth in NASDAQ Listing Rule 5635(c)), as such matters are not subject to shareholder approval under Israeli law. We will attempt to seek shareholder approval for our stock option or equity compensation plans (and the relevant annexes thereto) to the extent required in order to ensure they are tax qualified for our employees in the United States. However, if such approval is not received, then the stock option or equity compensation plans will continue to be in effect, but the Company will be unable to grant options to its U.S. employees that qualify as Incentive Stock Options for U.S. federal tax purpose. Our stock option or other equity compensation plans are also available to our non-U.S. employees, and provide features necessary to comply with applicable non-U.S. tax laws.
|
| 1.1 |
Amended and Restated Articles of Association, adopted on January 24, 2008, filed by us as an Exhibit to our registration statement on Form S-8, as filed with the Securities and Exchange Commission on February 11, 2008, and incorporated herein by reference
.
|
| 1.2 |
Amendment to Articles of Association of the Registrant incorporated by reference to Proposal 5 found in Exhibit 2 to the Form 6-K as filed with the Securities and Exchange Commission on March 1, 2012, and incorporated herein by reference.
|
| 4.1 |
Lease between the Company, C.P.M Medical Equipment Ltd. and Klimotech Ltd., for premises in Kfar Sava, Israel, dated December 3, 2014. As this lease is written in Hebrew, a summary is included in the Exhibit.
|
| 4.2 |
Sublease Agreement between the Company and Lumenis Ltd. for the site of our manufacturing facility in Yokne'am, Israel, dated August 1, 2013, and an amendment dated November 21, 2013, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2013, as filed with the Securities and Exchange Commission on March 20, 2014, and incorporated herein by reference. As this sublease agreement and the amendment are written in Hebrew, a summary was included in the Exhibit.
|
| 4.3 |
Lease between the Company and Naji Ezekiel & Sons - Management and Maintenance Ltd., for office space in Yokne'am Illit, dated as of August15, 2016. As this lease is written in Hebrew, a summary is filed herewith.
(*)
|
| 4.4 |
Lease between Silicom Connectivity Solutions, Inc. and RAD Data Communications Inc., for space in Mahwah, New Jersey, dated as of September 1, 1997, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2000, as filed with the Securities and Exchange Commission on June 30, 2001, and incorporated herein by reference.
|
| 4.5 |
Sublease Agreement between Silicom Connectivity Solutions, Inc. and Radcom Equipmet, Inc., for space in Paramus, New Jersey, dated as of February 1, 2004, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2003, as filed with the Securities and Exchange Commission on June 30, 2004, and incorporated herein by reference.
|
| 4.6 |
Lease agreement between Silicom Connectivity Solutions, Inc. and Zohar Zisapel Properties, Inc. and Yehuda Zisapel Properties, Inc., for space in Paramus, New Jersey, dated January 25, 2017.
(*)
|
| 4.7 |
The Executive Compensation Policy of the Company approved by the Shareholders on July 31, 2013, filed by us as Annex A to Proposal 1 found in Exhibit 2 to the Form 6-K as filed with the Securities and Exchange Commission on June 26, 2013, and incorporated herein by reference.
|
| 4.8 |
Share Purchase Agreement by and among the Company, Fiberblaze A/S, Fiberblaze Holding APS, and Hilmer APS, dated December 10, 2014.
|
| 4.9 |
Asset Purchase Agreement by and among the Company, the Company's wholly owned subsidiary Silicom Connectivity Solutions, Inc., ADI Engineering, Inc.,
Steve Yates and Patricia Yates, dated
September 30, 2015.
|
| 8. |
List of subsidiaries.
(*)
|
| 11.1 |
Code of Ethics, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2007, as filed with the Securities and Exchange Commission on March 26, 2008, and incorporated herein by reference.
|
| 12.1 |
Certification by Chief Executive Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
(*)
|
| 12.2 |
Certification by Chief Financial Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
(*)
|
| 13.1 |
Certification by Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(*)
|
| 13.2 |
Certification by Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(*)
|
| 15.1 |
Consent of Somekh Chaikin, Independent Registered Public Accounting Firm, a member firm of KPMG International.
(*)
|
|
|
SILICOM LIMITED
By: /S/ Shaike Orbach
Shaike Orbach
Chief Executive Officer
|
|
Page
|
|
|
F - 3
|
|
|
F - 4
|
|
|
F - 6
|
|
|
F - 7
|
|
|
F - 8
|
|
|
F - 9
|
|
2015
|
2016
|
||||||||||
|
Note
|
US$ thousands
|
US$ thousands
|
|||||||||
|
Assets
|
|||||||||||
|
Current assets
|
|||||||||||
|
Cash and cash equivalents
|
4
|
18,178
|
11,917
|
||||||||
|
Marketable securities
|
2F, 5
|
8,636
|
16,263
|
||||||||
|
Accounts receivable:
|
|||||||||||
|
Trade, net
|
2G
|
|
23,295
|
27,305
|
|||||||
|
Other
|
1,380
|
3,113
|
|||||||||
|
Related parties
|
473
|
417
|
|||||||||
|
Inventories
|
6
|
26,321
|
44,280
|
||||||||
|
Total current assets
|
78,283
|
103,295
|
|||||||||
|
Marketable securities
|
2F, 5
|
24,246
|
7,769
|
||||||||
|
Assets held for employees' severance benefits
|
9
|
1,374
|
1,436
|
||||||||
|
Deferred tax assets
|
14G
|
|
1,545
|
1,537
|
|||||||
|
Property, plant and equipment ("PPE"), net
|
7
|
3,825
|
3,915
|
||||||||
|
Intangible assets, net
|
8B
|
|
5,164
|
2,924
|
|||||||
|
Goodwill
|
8A
|
|
25,561
|
25,561
|
|||||||
|
Total assets
|
139,998
|
146,437
|
|||||||||
|
Avi Eizenman
|
Shaike Orbach
|
Eran Gilad
|
||
|
Chairman of the Board of Directors
|
Chief Executive Officer
|
Chief Financial Officer
|
|
2015
|
2016
|
||||||||||
|
Note
|
US$ thousands
|
US$ thousands
|
|||||||||
|
Liabilities and shareholders' equity
|
|||||||||||
|
Current liabilities
|
|||||||||||
|
Trade accounts payable
|
8,544
|
10,476
|
|||||||||
|
Other accounts payable and accrued expenses
|
11,147
|
7,484
|
|||||||||
|
Related parties
|
12
|
4
|
|||||||||
|
Total current liabilities
|
19,703
|
17,964
|
|||||||||
|
Long-term liabilities
|
|||||||||||
|
Contingent consideration
|
3
|
4,942
|
4,642
|
||||||||
|
Liability for employees' severance benefits
|
9
|
2,251
|
2,439
|
||||||||
|
Deferred tax liabilities
|
14G
|
|
268
|
-
|
|||||||
|
Total liabilities
|
27,164
|
25,045
|
|||||||||
|
Commitments and contingencies
|
10
|
||||||||||
|
Shareholders' equity
|
11
|
||||||||||
|
Ordinary shares, ILS 0.01 par value; 10,000,000 shares
|
|||||||||||
|
authorized; 7,299,315 and 7,396,584 issued as at
|
|||||||||||
|
December 31, 2015 and 2016, respectively;
|
|||||||||||
|
7,284,344 and 7,381,613 outstanding as at
|
|||||||||||
|
December 31, 2015 and 2016, respectively
|
21
|
22
|
|||||||||
|
Additional paid-in capital
|
44,101
|
46,833
|
|||||||||
|
Treasury shares (at cost) - 14,971 ordinary shares as at
|
|||||||||||
|
December 31, 2015 and 2016
|
(38
|
)
|
(38
|
)
|
|||||||
|
Retained earnings
|
68,750
|
74,575
|
|||||||||
|
Total shareholders' equity
|
112,834
|
121,392
|
|||||||||
|
Total liabilities and shareholders' equity
|
139,998
|
146,437
|
|||||||||
|
2014
|
2015
|
2016
|
|||||||||||||
|
US$ thousands
|
|||||||||||||||
|
Note
|
Except for share and per share data
|
||||||||||||||
|
Sales*
|
12
|
75,622
|
82,738
|
100,347
|
|||||||||||
|
Cost of sales
|
44,835
|
48,659
|
61,796
|
||||||||||||
|
Gross profit
|
30,787
|
34,079
|
38,551
|
||||||||||||
|
Operating expenses
|
|||||||||||||||
|
Research and development**
|
6,480
|
9,702
|
12,663
|
||||||||||||
|
Sales and marketing
|
4,418
|
5,651
|
6,423
|
||||||||||||
|
General and administrative
|
2,798
|
3,611
|
3,969
|
||||||||||||
|
Contingent consideration expense (benefit)
|
3
|
45
|
(3,090
|
)
|
(334
|
)
|
|||||||||
|
Total operating expenses
|
13,741
|
15,874
|
22,721
|
||||||||||||
|
Operating income
|
17,046
|
18,205
|
15,830
|
||||||||||||
|
Financial income, net
|
13
|
263
|
220
|
35
|
|||||||||||
|
Income before income taxes
|
17,309
|
18,425
|
15,865
|
||||||||||||
|
Income taxes
|
14
|
2,704
|
1,905
|
2,728
|
|||||||||||
|
Net income
|
14,605
|
16,520
|
13,137
|
||||||||||||
|
Income per share:
|
|||||||||||||||
|
Basic income per ordinary share (US$)
|
2S
|
|
2.033
|
2.273
|
1.789
|
||||||||||
|
Diluted income per ordinary share (US$)
|
1.996
|
2.242
|
1.767
|
||||||||||||
|
Weighted average number of ordinary
|
|||||||||||||||
|
shares used to compute basic income
|
|||||||||||||||
|
per share (in thousands)
|
7,184
|
7,269
|
7,344
|
||||||||||||
|
Weighted average number of ordinary
|
|||||||||||||||
|
shares used to compute diluted income
|
|||||||||||||||
|
per share (in thousands)
|
7,319
|
7,368
|
7,435
|
||||||||||||
|
Ordinary shares
|
Additional
paid-in capital
|
Treasury
shares
|
Retained
earnings
|
Total
shareholders'
equity
|
||||||||||||||||||||
|
Number
of shares
(1)
|
US$ thousands
|
|||||||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
January 1, 2014
|
7,140,013
|
21
|
38,626
|
(38
|
)
|
52,082
|
90,691
|
|||||||||||||||||
|
Exercise of options
|
78,620
|
*-
|
1,353
|
-
|
-
|
1,353
|
||||||||||||||||||
|
Share-based compensation
|
-
|
-
|
1,266
|
-
|
-
|
1,266
|
||||||||||||||||||
|
Dividend
(US $1.00 per share)
|
-
|
-
|
-
|
-
|
(7,183
|
)
|
(7,183
|
)
|
||||||||||||||||
|
Net income
|
-
|
-
|
-
|
-
|
14,605
|
14,605
|
||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
December 31, 2014
|
7,218,633
|
21
|
41,245
|
(38
|
)
|
59,504
|
100,732
|
|||||||||||||||||
|
Exercise of options and
RSU
s
(2)
|
65,711
|
*-
|
943
|
-
|
-
|
943
|
||||||||||||||||||
|
Share-based compensation
|
-
|
-
|
1,913
|
-
|
-
|
1,913
|
||||||||||||||||||
|
Dividend
(US $1.00 per share)
|
-
|
-
|
-
|
-
|
(7,274
|
)
|
(7,274
|
)
|
||||||||||||||||
|
Net income
|
-
|
-
|
-
|
-
|
16,520
|
16,520
|
||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
December 31, 2015
|
7,284,344
|
21
|
44,101
|
(38
|
)
|
68,750
|
112,834
|
|||||||||||||||||
|
Exercise of options and
RSU
s
(2)
|
97,269
|
1
|
951
|
-
|
-
|
952
|
||||||||||||||||||
|
Share-based compensation
|
-
|
-
|
1,781
|
-
|
-
|
1,781
|
||||||||||||||||||
|
Dividend
(US $1.00 per share)
|
-
|
-
|
-
|
-
|
(7,312
|
)
|
(7,312
|
)
|
||||||||||||||||
|
Net income
|
-
|
-
|
-
|
-
|
13,137
|
13,137
|
||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
December 31, 2016
|
7,381,613
|
22
|
46,833
|
(38
|
)
|
74,575
|
121,392
|
|||||||||||||||||
|
(1)
|
Net of 14,971 shares held by Silicom Inc.
|
|||||
|
(2)
|
Restricted share units (hereinafter - "RSUs")
|
|||||
|
*
|
Less than 1 thousand.
|
|
2014
|
2015
|
2016
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Cash flows from operating activities
|
||||||||||||
|
Net income
|
14,605
|
16,520
|
13,137
|
|||||||||
|
Adjustments required to reconcile net income to
|
||||||||||||
|
net cash provided by (used in) operating activities:
|
||||||||||||
|
Depreciation and amortization
|
996
|
2,767
|
3,856
|
|||||||||
|
Write-down of obsolete inventory
|
1,029
|
219
|
3,170
|
|||||||||
|
Change in liability for employees' severance benefits, net
|
(86
|
)
|
(112
|
)
|
126
|
|||||||
|
Discount on marketable securities, net
|
758
|
561
|
358
|
|||||||||
|
Share-based compensation expense
|
1,266
|
1,998
|
1,550
|
|||||||||
|
Deferred taxes income
|
(219
|
)
|
(907
|
)
|
(260
|
)
|
||||||
|
Capital gain
|
-
|
(3
|
)
|
-
|
||||||||
|
Changes in assets and liabilities:
|
||||||||||||
|
Accounts receivable - trade
|
(3,248
|
)
|
(4,850
|
)
|
(4,007
|
)
|
||||||
|
Accounts receivable - other
|
188
|
127
|
(1,832
|
)
|
||||||||
|
Accounts receivable - related parties
|
(6
|
)
|
(83
|
)
|
56
|
|||||||
|
Inventories
|
3,416
|
(939
|
)
|
(21,426
|
)
|
|||||||
|
Trade accounts payable
|
1,321
|
234
|
1,809
|
|||||||||
|
Other accounts payable and accrued expenses
|
649
|
853
|
1,098
|
|||||||||
|
Contingent consideration adjustments
|
45
|
(3,090
|
)
|
(334
|
)
|
|||||||
|
Accounts payable - related parties
|
(30
|
)
|
(8
|
)
|
(8
|
)
|
||||||
|
Net cash provided by (used in) operating activities
|
20,684
|
13,287
|
(2,707
|
)
|
||||||||
|
Cash flows from investing activities
|
||||||||||||
|
Proceeds from (investments in) short term bank deposits, net
|
(1,000
|
)
|
4,000
|
-
|
||||||||
|
Sale of property, plant and equipment
|
-
|
19
|
-
|
|||||||||
|
Purchase of property, plant and equipment
|
(1,858
|
)
|
(2,984
|
)
|
(1,441
|
)
|
||||||
|
Investment in intangible assets
|
(100
|
)
|
-
|
-
|
||||||||
|
Proceeds from maturity of marketable securities
|
14,750
|
15,100
|
8,575
|
|||||||||
|
Purchases of marketable securities
|
(11,740
|
)
|
(12,935
|
)
|
-
|
|||||||
|
Business acquisition, net of acquired cash (see Note 3)
|
(10,048
|
)
|
(10,000
|
)
|
-
|
|||||||
|
Net cash provided by (used in) investing activities
|
(9,996
|
)
|
(6,800
|
)
|
7,134
|
|||||||
|
Cash flows from financing activities
|
||||||||||||
|
Exercise of options
|
1,353
|
943
|
952
|
|||||||||
|
Dividend
|
(7,183
|
)
|
(7,274
|
)
|
(7,312
|
)
|
||||||
|
Payment made in connection with contingent consideration
|
-
|
-
|
(4,463
|
)
|
||||||||
|
Net cash used in financing activities
|
(5,830
|
)
|
(6,331
|
)
|
(10,823
|
)
|
||||||
|
Effect of exchange rate changes on cash balances held
|
35
|
132
|
135
|
|||||||||
|
Increase (decrease) in cash and cash equivalents
|
4,893
|
288
|
(6,261
|
)
|
||||||||
|
Cash and cash equivalents at beginning of year
|
12,997
|
17,890
|
18,178
|
|||||||||
|
Cash and cash equivalents at end of year
|
17,890
|
18,178
|
11,917
|
|||||||||
|
Supplementary cash flow information
|
||||||||||||
|
A. Non-cash transactions:
|
||||||||||||
|
Investments in PPE and intangible assets
|
87
|
72
|
39
|
|||||||||
|
B. Cash paid during the year for:
|
||||||||||||
|
Income taxes
|
1,277
|
4,487
|
4,648
|
|||||||||
| A. |
Financial statements in US dollars
|
| B. |
Basis of presentation
|
| C. |
Estimates and assumptions
|
| D. |
Business combinations
|
| E. |
Cash and cash equivalents
|
| F. |
Marketable securities
|
| F. |
Marketable securities (
cont'd
)
|
| G. |
Trade accounts receivable, net
|
| H. |
Inventories
|
| I. |
Assets held for employees' severance benefits
|
| J. |
Property, plant and equipment
|
|
%
|
||||
|
Machinery and equipment
|
15 - 33
|
|||
|
Office furniture and equipment
|
6 - 33
|
|||
|
Leasehold improvements
|
*
|
|||
| K. |
Goodwill and other intangible assets
|
| K. |
Goodwill and other intangible assets (cont'd)
|
| L. |
Impairment of Long-Lived Assets
|
| M. |
Revenue recognition
|
| N. |
Research and development costs
|
| O. |
Allowance for product warranty
|
| P. |
Treasury shares
|
| Q. |
Income taxes
|
| R. |
Share-based compensation
|
| S. |
Basic and diluted earnings per share
|
| S. |
Basic and diluted earnings per share (cont'd)
|
|
Year ended December 31
|
||||||||||||
|
2014
|
2015
|
2016
|
||||||||||
|
Net income attributable to ordinary shares
|
||||||||||||
|
(US$ thousands)
|
14,605
|
16,520
|
13,137
|
|||||||||
|
Weighted average number of ordinary shares outstanding
|
||||||||||||
|
used in basic income per ordinary share calculation
|
7,184,114
|
7,268,536
|
7,343,696
|
|||||||||
|
Add assumed exercise of outstanding dilutive potential
|
||||||||||||
|
ordinary shares
|
134,792
|
99,448
|
91,485
|
|||||||||
|
Weighted average number of ordinary shares outstanding
|
||||||||||||
|
used in diluted income per ordinary share calculation
|
7,318,906
|
7,367,984
|
7,435,181
|
|||||||||
|
Basic income per ordinary shares (US$)
|
2.033
|
2.273
|
1.789
|
|||||||||
|
Diluted income per ordinary shares (US$)
|
1.996
|
2.242
|
1.767
|
|||||||||
|
The weighted average number of shares related to options
|
||||||||||||
|
and RSUs excluded from the diluted earnings per share
|
||||||||||||
|
calculation because of anti-dilutive effect
|
37,304
|
43,181
|
9,633
|
|||||||||
| T. |
Comprehensive Income
|
| U. |
Fair Value Measurements
|
| U. |
Fair Value Measurements (cont'd)
|
| V. |
Concentrations of risks
|
| W. |
Liabilities for loss contingencies
|
| X. |
Recent Accounting Pronouncements
|
| (1) |
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The standard can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company has not yet selected a transition method and is evaluating the impact of adopting the standard on its ongoing financial reporting.
Based on the Company's assessment as of the date of these financial statements, the impact of adopting the new standard is not expected to be material.
|
| (2) |
In July 2015, the FASB issued ASU 2015-11, which, for entities that do not measure inventory using the last-in, first-out (LIFO) or retail inventory method, changes the measurement principle for inventory from the lower of cost or market to lower of cost and net realizable value. The ASU also eliminates the requirement for these entities to consider replacement cost or net realizable value less an approximately normal profit margin when measuring inventory. This ASU is effective in fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. This ASU is to be applied prospectively. Early adoption is permitted as of the beginning of an interim or annual period.
|
| (3) |
In November 2015, the FASB issued ASU 2015-17, which requires entities with a classified balance sheet to present all deferred tax assets and liabilities as noncurrent.
This
ASU is effective for interim and annual periods in fiscal years beginning after December 15, 2016. Early adoption is permitted.
|
| X. |
Recent Accounting Pronouncements (cont'd)
|
| (4) |
In February 2016, the FASB issued ASU 2016-02, which requires lessees to recognize most of their leases on balance sheet as a right-of-use asset and a lease liability.
This
ASU is effective for interim and annual periods in fiscal years beginning after December 15, 2018. Early adoption is permitted.
|
| (5) |
On March 30, 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting, which is intended to improve the accounting for share-based payment transactions as part of the FASB's simplification initiative.
This ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2016.
Early adoption is permitted in any interim or annual period provided that the entire ASU is adopted.
|
| (6) |
In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, which significantly changes the way entities recognize impairment of many financial assets by requiring immediate recognition of estimated credit losses expected to occur over their remaining life.
This
ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2019. Early adoption is permitted for annual and interim periods in fiscal years beginning after December 15, 2018.
|
| A. |
ADI Engineering, Inc.
|
| B. |
Fiberblaze
|
|
Note 4 - Cash and Cash Equivalents
|
|
December 31
|
||||||||
|
2015
|
2016
|
|||||||
|
US$ thousands
|
||||||||
|
Cash
|
12,329
|
5,858
|
||||||
|
Cash equivalents *
|
5,849
|
6,059
|
||||||
|
18,178
|
11,917
|
|||||||
|
*
|
Comprised mainly of deposits in banks as at December 31, 2015 and 2016 carrying a weighted average interest rate of 0.11% and 0.30%, respectively.
|
|
Note 5 - Marketable Securities
|
|
Gross
|
Gross
|
|||||||||||||||
|
unrealized
|
unrealized
|
|||||||||||||||
|
Amortized
|
holding
|
holding
|
Aggregate
|
|||||||||||||
|
cost basis**
|
gains
|
(losses)
|
fair value*
|
|||||||||||||
|
US$ thousands
|
||||||||||||||||
|
At December 31, 2016
|
||||||||||||||||
|
Held to maturity:
|
||||||||||||||||
|
Corporate debt securities
|
||||||||||||||||
|
Current
|
16,390
|
-
|
(97
|
)
|
16,293
|
|||||||||||
|
Non-Current
|
7,815
|
-
|
(62
|
)
|
7,753
|
|||||||||||
|
24,205
|
-
|
(159
|
)
|
24,046
|
||||||||||||
|
At December 31, 2015
|
||||||||||||||||
|
Held to maturity:
|
||||||||||||||||
|
Corporate debt securities
|
||||||||||||||||
|
Current
|
8,720
|
-
|
(90
|
)
|
8,630
|
|||||||||||
|
Non-Current
|
24,418
|
-
|
(255
|
)
|
24,163
|
|||||||||||
|
33,138
|
-
|
(345
|
)
|
32,793
|
||||||||||||
|
*
|
Fair value is being determined using quoted market prices in active markets (Level 1).
|
|
**
|
Including accrued interest in the amount of US$ 256 thousand and US$ 173 thousand as of December 31, 2015 and 2016 respectively.
The accrued interest is presented as part of other account receivable on the balance sheet.
|
|
Activity in marketable securities in 2016
|
US$ thousands
|
|||
|
Balance at January 1, 2016
|
33,138
|
|||
|
Discount on marketable securities, net
|
(358
|
)
|
||
|
Proceeds from maturity of marketable securities
|
(8,575
|
)
|
||
|
Balance at December 31, 2016
|
24,205
|
|||
|
Note 5 - Marketable Securities (Cont'd)
|
|
Less than 12 months
|
12 months or more
|
Total
|
||||||||||||||||||||||
|
Unrealized Losses
|
Fair value
|
Unrealized Losses
|
Fair value
|
Unrealized Losses
|
Fair value
|
|||||||||||||||||||
|
Held to maturity:
|
||||||||||||||||||||||||
|
Corporate debt securities
|
-
|
-
|
(159
|
)
|
24,046
|
(159
|
)
|
24,046
|
||||||||||||||||
|
Note 6 - Inventories
|
|
December 31
|
||||||||
|
2015
|
2016
|
|||||||
|
US$ thousands
|
||||||||
|
Raw materials and components
|
9,598
|
16,435
|
||||||
|
Products in process
|
9,013
|
19,098
|
||||||
|
Finished products
|
7,710
|
8,747
|
||||||
|
26,321
|
44,280
|
|||||||
|
Note 7 - Property, Plant and Equipment, Net
|
|
December 31
|
||||||||
|
2015
|
2016
|
|||||||
|
US$ thousands
|
||||||||
|
Machinery and equipment
|
6,906
|
8,507
|
||||||
|
Office furniture and equipment
|
608
|
634
|
||||||
|
Leasehold improvements
|
2,205
|
2,277
|
||||||
|
Property, plant and equipment
|
9,719
|
11,418
|
||||||
|
Accumulated depreciation
|
(5,894
|
)
|
(7,503
|
)
|
||||
|
Property, Plant and equipment, net
|
3,825
|
3,915
|
||||||
|
A.
|
Goodwill
|
|
December 31
|
||||||||
|
2015
|
2016
|
|||||||
|
US$ thousands
|
||||||||
|
Beginning of the year
|
12,242
|
25,561
|
||||||
|
Business acquisition (see Note 3A)
|
13,319
|
-
|
||||||
|
End of the year
|
25,561
|
25,561
|
||||||
|
B.
|
Other intangible assets
|
|
December 31
|
|||||||||||
|
2015
|
2016
|
||||||||||
|
Useful life
|
US$ thousands
|
||||||||||
|
Original cost:
|
|||||||||||
|
Intellectual property
|
3
|
200
|
200
|
||||||||
|
Current technology
|
3
|
3,833
|
3,833
|
||||||||
|
Customer relationships
|
3
|
1,937
|
1,937
|
||||||||
|
Backlog
|
0.4
|
487
|
487
|
||||||||
|
6,457
|
6,457
|
||||||||||
|
Accumulated amortization:
|
|||||||||||
|
Intellectual property
|
154
|
200
|
|||||||||
|
Current technology
|
654
|
1,930
|
|||||||||
|
Customer relationships
|
272
|
916
|
|||||||||
|
Backlog
|
213
|
487
|
|||||||||
|
1,293
|
3,533
|
||||||||||
|
Other intangible assets, Net:
|
|||||||||||
|
Intellectual property
|
46
|
-
|
|||||||||
|
Current technology
|
3,179
|
1,903
|
|||||||||
|
Customer relationships
|
1,665
|
1,021
|
|||||||||
|
Backlog
|
274
|
-
|
|||||||||
|
5,164
|
2,924
|
||||||||||
| A. |
Under Israeli law and labor agreements, Silicom is required to make severance payments to retired or dismissed employees and to employees leaving employment in certain other circumstances.
|
| B. |
According to Section 14 to the Severance Pay Law ("Section 14") the payment of monthly deposits by a company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to the employees that have entered into agreements with the company pursuant to such Section 14. Commencing July 1, 2008, the Company has entered into agreements with a majority of its employees in order to implement Section 14. Therefore, as of that date, the payment of monthly deposits by the Company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to those employees that have entered into such agreements and therefore the Company incurs no additional liability since that date with respect to such employees. Amounts accumulated in the pension funds or insurance policies pursuant to Section 14 are not supervised or administrated by the Company and therefore neither such amounts nor the corresponding accrual are reflected in the balance sheet.
|
| C. |
Consequently, the assets held for employees' severance benefits reported on the balance sheet, in respect of deposits for those employees who have signed agreements pursuant to Section 14, represent the redemption value of deposits made through June 30, 2008. The liability for employee severance benefits, with respect to those employees, represents the liability of the Company for employees' severance benefits as of June 30, 2008.
|
| D. |
Expenses recorded with respect to employees' severance payments for the years ended December 31, 2014, 2015 and 2016 were US$ 432 thousand, US$ 543 thousand and US$ 761 thousand, respectively.
|
|
Year ended December 31
|
US$ thousands
|
|||
|
2017
|
1,481
|
|||
|
2018
|
1,140
|
|||
|
2019 and on
|
1,159
|
|||
|
A.
|
On July 21, 2004, the Board resolved, subject to shareholders' approval that was given on December 30, 2004, to adopt the Share Option Plan (2004) (the "2004 Plan"). Option grants to employees under the 2004 Plan, including terms of vesting and the exercise price, are subject to the Board of Directors' approval. Option grants to directors and certain other officers are generally subject to the approvals of the Compensation Committee as well as Board of Directors, and grants to directors or a CEO will also generally have to be approved by the Shareholders. The term of the options shall not exceed 10 years from the date that the option was granted.
|
|
B.
|
Options or RSUs granted to Israeli residents may be granted under Section 102 of the Israeli Income Tax Ordinance pursuant to which the awards of options, or the ordinary shares issued upon their exercise, must be deposited with a trustee for at least two years following the date of grant. Under Section 102, any tax payable by an employee from the grant or exercise of the awards is deferred until the transfer of the awards or ordinary shares by the trustee to the employee or upon the sale of the awards or ordinary shares.
|
|
C.
|
During 2014 and 2015, the Company granted 74,000 and 8,000 RSUs respectively to certain of its directors, employees and consultants under the 2013 Plan. In relation to those grants:
|
| 1. |
The vesting period of the RSUs ranges between 2 to 3 years from the date of grant.
|
| 2. |
The fair value of RSUs is estimated based on the market value of the Company's stock on the date of grant, less an estimate of dividends that will not accrue to RSUs holders prior to vesting.
|
| 3. |
The Company recognizes compensation expenses on these RSUs based on estimated grant date fair value, with the following assumptions:
|
|
2014
|
2015
|
|||||||
|
Expected dividend yield
|
2.06
|
%
|
3.22
|
%
|
||||
|
Termination rate
|
4.35
|
%
|
0
|
%
|
||||
|
D.
|
On July 28, 2015, the Company granted, in the aggregate, 89,907 options to certain of its directors and employees under the 2013 Plan. In relation to this grant:
|
| 1. |
The exercise price for the options (per ordinary share) was US$ 26.91 and the Option expiration date was the earlier to occur of: (a) July 28, 2023; and (b) the closing price of the shares falling below US$ 13.46 at any time after the date of grant. The options vest and become exercisable on the second anniversary of the date of grant.
|
| 2. |
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:
|
|
Average Risk-free interest rate
(a)
|
2.08
|
%
|
||
|
Expected dividend yield
|
2.09
|
%
|
||
|
Average expected volatility
(b)
|
53.01
|
%
|
||
|
Termination rate
|
9
|
%
|
||
|
Suboptimal factor
(c)
|
3.4
|
|
(a)
|
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
|
|
(b)
|
Expected average volatility represents a weighted average standard deviation rate for the price of the Company's ordinary shares on the NASDAQ National Market.
|
|
(c)
|
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
|
|
E.
|
On June 8, 2016, the Company granted, in the aggregate, 93,660 options to certain of its directors and employees under the 2013 Plan. In relation to this grant:
|
|
1.
|
The exercise price for the options (per ordinary share) was US$ 28.38 and the Option expiration date was the earlier to occur of: (a) June 8, 2024; and (b) the closing price of the shares falling below US$ 14.19 at any time after the date of grant. The options vest and become exercisable on the second anniversary of the date of grant.
|
|
2.
|
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:
|
|
Average Risk-free interest rate
(a)
|
1.58
|
%
|
||
|
Expected dividend yield
|
2.42
|
%
|
||
|
Average expected volatility
(b)
|
47.90
|
%
|
||
|
Termination rate
|
9
|
%
|
||
|
Suboptimal factor
(c)
|
3.32
|
|
(a)
|
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
|
|
(b)
|
Expected average volatility represents a weighted average standard deviation rate for the price of the Company's ordinary shares on the NASDAQ National Market.
|
|
(c)
|
Suboptimal factor represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal factor of the Company and similar companies.
|
|
Note 11- Shareholders' Equity (cont'd)
|
|
F.
|
The following table summarizes information regarding stock options as at December 31, 2016:
|
|
Options outstanding
|
Options exercisable
|
||||||||||||||||
|
Weighted average
|
Weighted average
|
||||||||||||||||
|
remaining
|
remaining
|
||||||||||||||||
|
Exercise price
|
Number
|
contractual life
|
Number
|
contractual life
|
|||||||||||||
|
US$
|
of options
|
(in years)
|
of options
|
(in years)
|
|||||||||||||
|
15.28
|
66,775
|
3.7
|
66,775
|
3.7
|
|||||||||||||
|
26.91
|
86,990
|
6.6
|
-
|
-
|
|||||||||||||
|
33.27
|
20,499
|
9.3
|
6,833
|
9.3
|
|||||||||||||
|
28.38
|
91,741
|
7.4
|
-
|
-
|
|||||||||||||
|
266,005
|
73,608
|
||||||||||||||||
|
Note 11- Shareholders' Equity (cont'd)
|
|
G.
|
The stock option activity under the abovementioned plans is as follows:
|
|
Weighted
|
||||||||||||
|
Weighted
|
average
|
|||||||||||
|
Number
|
average
|
grant date
|
||||||||||
|
of options
|
exercise price
|
fair value
|
||||||||||
|
US$
|
US$
|
|||||||||||
|
Balance at January 1, 2014
|
272,750
|
|||||||||||
|
Exercised
|
(78,620
|
)
|
17.19
|
7.70
|
||||||||
|
Forfeited
|
(2,000
|
)
|
15.28
|
6.54
|
||||||||
|
Balance at December 31, 2014
|
192,130
|
|||||||||||
|
Granted
|
89,907
|
26.91
|
10.04
|
|||||||||
|
Exercised
|
(61,711
|
)
|
15.28
|
6.54
|
||||||||
|
Forfeited
|
(5,625
|
)
|
24.07
|
9.19
|
||||||||
|
Balance at December 31, 2015
|
214,701
|
|||||||||||
|
Granted*
|
116,455
|
29.34
|
10.96
|
|||||||||
|
Exercised
|
(62,269
|
)
|
15.28
|
6.54
|
||||||||
|
Forfeited
|
(2,882
|
)
|
29.71
|
11.79
|
||||||||
|
Balance at December 31, 2016
|
266,005
|
|||||||||||
|
Exercisable at December 31, 2016
|
73,608
|
|||||||||||
|
*
|
In 2016 the Company granted in the aggregate, 116,455 options. Regarding the grant of 93,660 options, see Note 11E. Regarding the grant of 22,795 options, see Note 3B.
|
|
Note 11- Shareholders' Equity (cont'd)
|
|
H.
|
The Restricted Share Units activity under the abovementioned plans is as follows:
|
|
Weighted
|
||||||||
|
Number of
|
average
|
|||||||
|
Restricted
|
grant date
|
|||||||
|
Share Units
|
fair value
|
|||||||
|
US$
|
US$
|
|||||||
|
Balance at January 1, 2014
|
-
|
|||||||
|
Granted
|
74,000
|
46.07
|
||||||
|
Balance at December 31, 2014
|
74,000
|
|||||||
|
Granted
|
8,000
|
29.09
|
||||||
|
Vested
|
(4,000
|
)
|
46.07
|
|||||
|
Balance at December 31, 2015
|
78,000
|
|||||||
|
Vested
|
(35,000
|
)
|
46.54
|
|||||
|
Balance at December 31, 2016
|
43,000
|
|||||||
|
Note 11- Shareholders' Equity (cont'd)
|
|
I.
|
During 2014, 2015 and 2016, the Company recorded share-based compensation expenses. The following summarizes the allocation of the stock-based compensation expenses:
|
|
Year ended December 31
|
||||||||||||
|
2014
|
2015
|
2016
|
||||||||||
|
US$ thousands
|
US$ thousands
|
US$ thousands
|
||||||||||
|
Cost of sales
|
124
|
150
|
180
|
|||||||||
|
Research and development costs
|
340
|
455
|
504
|
|||||||||
|
Selling and marketing expenses
|
366
|
502
|
366
|
|||||||||
|
General and administrative expenses
|
436
|
806
|
500
|
|||||||||
|
1,266
|
1,913
|
1,550
|
||||||||||
|
Note 12- Geographic areas and major customers
|
||||||||
|
A.
|
Information on sales by geographic distribution:
|
|
Year ended December 31
|
||||||||||||
|
2014
|
2015
|
2016
|
||||||||||
|
US$ thousands
|
||||||||||||
|
North America
|
53,712
|
54,537
|
65,590
|
|||||||||
|
Europe
|
11,421
|
16,331
|
24,208
|
|||||||||
|
Asia-Pacific
|
10,489
|
11,870
|
10,549
|
|||||||||
|
75,622
|
82,738
|
100,347
|
||||||||||
|
B.
|
Sales to single customers exceeding 10% of sales (US$ thousands):
|
|
Year ended December 31
|
||||||||||||
|
2014
|
2015
|
2016
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Customer "A"
|
18,083
|
16,320
|
17,366
|
|||||||||
|
Customer "B"
|
*
|
*
|
11,628
|
|||||||||
|
Note 12- Geographic areas and major customers (cont'd)
|
|||||||
|
C.
|
Information on Long lived assets by geographic areas:
|
|
Year ended December 31
|
||||||||
|
2015
|
2016
|
|||||||
|
US$ thousands
|
||||||||
|
North America
|
22
|
16
|
||||||
|
Europe
|
13,588
|
12,945
|
||||||
|
Israel
|
20,894
|
19,439
|
||||||
|
Other
|
46
|
-
|
||||||
|
34,550
|
32,400
|
|||||||
|
Note 13- Financial Income (Expenses), Net
|
|
Year ended December 31
|
||||||||||||
|
2014
|
2015
|
2016
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Interest income
|
1,266
|
1,026
|
751
|
|||||||||
|
Discount on marketable securities, net
|
(758
|
)
|
(561
|
)
|
(358
|
)
|
||||||
|
Exchange rate differences, net
|
(95
|
)
|
(148
|
)
|
(236
|
)
|
||||||
|
Bank charges
|
(150
|
)
|
(97
|
)
|
(122
|
)
|
||||||
|
263
|
220
|
35
|
||||||||||
| A. |
Measurement of results for tax purposes under the Israeli Income Tax Regulations (Rules for Maintaining Accounting Records of Foreign Invested Companies and Certain Partnerships and Determining Their Taxable Income) - 1986
|
| B. |
Corporate tax rate in Israel
|
| C. |
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the "Law")
|
|
1.
|
On December 29, 2010 the Knesset approved the Economic Policy Law for 2011-2012, which includes an amendment to the Law for the Encouragement of Capital Investments – 1959 (hereinafter – "the Amendment to the Law"). The Amendment to the Law is effective from January 1, 2011 and its provisions will apply to preferred income derived or accrued in 2011 and thereafter by a Preferred Company, per the definition of these terms in the Amendment to the Law.
|
| C. |
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the "Law") (cont'd)
|
|
2.
|
In the event of distribution by the Company of cash dividends out of its retained earnings that were generated prior to 2014 tax year and were tax exempt due to the "Approved Enterprise" or "Benefited Enterprise" status, the Company would be subjected to a maximum of 25% corporate tax on the amount distributed, and a further 15% withholding tax would be deducted from the amounts distributed to the shareholders.
|
| 1. |
The subsidiary Silicom Connectivity Solutions, Inc. files tax returns to US federal tax authorities and to state tax authorities in the states of New Jersey, California and Virginia.
|
| 2. |
The subsidiary Fiberblaze is taxed according to the tax laws in Denmark and its subsidiary files tax returns to US federal tax authorities, New York state tax authorities and to the city of New York tax authorities.
|
| 3. |
The Company has not provided for Israeli income and foreign withholding taxes on US$ 2,871 thousand of its non-Israeli subsidiaries' undistributed earnings as of December 31, 2016. The earnings could become subject to tax if earnings are remitted or deemed remitted as dividends or upon sale of a subsidiary.
|
| 4. |
As of December 31, 2016, the net operating loss carry-forwards of the Company's subsidiaries for tax purposes amounted to approximately US$ 1,500 thousand. These losses are available to offset any future taxable income.
|
|
Note 14- Taxes on Income (cont'd)
|
|
F.
|
Income before income taxes and income taxes expense (benefit) included in the consolidated statements of operations
|
|
Year ended December 31
|
||||||||||||
|
2014
|
2015
|
2016
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Income (loss) before income taxes:
|
||||||||||||
|
Israel
|
16,522
|
19,486
|
15,541
|
|||||||||
|
Foreign jurisdiction
|
787
|
(1,061
|
)
|
324
|
||||||||
|
17,309
|
18,425
|
15,865
|
||||||||||
|
Current taxes:
|
||||||||||||
|
Israel
|
2,494
|
2,383
|
2,242
|
|||||||||
|
Foreign jurisdiction
|
409
|
465
|
720
|
|||||||||
|
2,903
|
2,848
|
2,962
|
||||||||||
|
Current tax (benefits) expenses relating to prior years:
|
||||||||||||
|
Israel
|
20
|
-
|
26
|
|||||||||
|
Foreign jurisdiction
|
-
|
(36
|
)
|
-
|
||||||||
|
20
|
(36
|
)
|
26
|
|||||||||
|
Deferred taxes:
|
||||||||||||
|
Israel
|
(200
|
)
|
(437
|
)
|
10
|
|||||||
|
Foreign jurisdiction
|
(19
|
)
|
(470
|
)
|
(270
|
)
|
||||||
|
(219
|
)
|
(907
|
)
|
(260
|
)
|
|||||||
|
Income tax expense
|
2,704
|
1,905
|
2,728
|
|||||||||
|
December 31
|
December 31
|
|||||||
|
2015
|
2016
|
|||||||
|
US$ thousands
|
US$ thousands
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Accrued employee benefits
|
247
|
261
|
||||||
|
Research and development costs
|
679
|
921
|
||||||
|
Tax loss carryforwards
|
177
|
338
|
||||||
|
PPE
|
16
|
15
|
||||||
|
Inventory
|
160
|
-
|
||||||
|
Share based compensation
|
245
|
246
|
||||||
|
Intangible assets
|
-
|
107
|
||||||
|
Other
|
21
|
2
|
||||||
|
Total gross deferred tax assets
|
1,545
|
1,890
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Intangible assets
|
(243
|
)
|
(138
|
)
|
||||
|
Goodwill
|
(61
|
)
|
(215
|
)
|
||||
|
Other
|
36
|
-
|
||||||
|
Total gross deferred tax liabilities
|
(268
|
)
|
(353
|
)
|
||||
|
Net deferred tax assets
|
1,277
|
1,537
|
||||||
|
In Israel
|
1,348
|
1,338
|
||||||
|
Foreign jurisdictions
|
(71
|
)
|
199
|
|||||
|
Net deferred tax assets
|
1,277
|
1,537
|
||||||
|
Non-current deferred tax assets
|
1,545
|
1,537
|
||||||
|
Non-current deferred tax liabilities
|
(268
|
)
|
-
|
|||||
|
Net deferred tax assets
|
1,277
|
1,537
|
||||||
|
Note 14- Taxes on Income (cont'd)
|
|||||||
|
H.
|
Reconciliation of the statutory tax expense to actual tax expense
|
|
Year ended December 31
|
||||||||||||
|
2014
|
2015
|
2016
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Income before income taxes
|
17,309
|
18,425
|
15,865
|
|||||||||
|
Statutory tax rate in Israel
|
26.5
|
%
|
26.5
|
%
|
25.0
|
%
|
||||||
|
4,587
|
4,883
|
3,966
|
||||||||||
|
Increase (decrease) in taxes resulting from:
|
||||||||||||
|
Non-deductible operating expenses, net
|
476
|
209
|
228
|
|||||||||
|
Non-taxable income
|
-
|
(819
|
)
|
(84
|
)
|
|||||||
|
Prior year adjustments
|
20
|
(36
|
)
|
26
|
||||||||
|
Tax effect due to "Approved/Benefited/
|
||||||||||||
|
Preferred Enterprise" status
|
(2,588
|
)
|
(2,368
|
)
|
(1,924
|
)
|
||||||
|
Taxes related to foreign jurisdictions
|
181
|
250
|
324
|
|||||||||
|
Changes in tax rate
|
-
|
35
|
94
|
|||||||||
|
Creation of deferred taxes for tax losses and
|
||||||||||||
|
benefits from previous years for which deferred
|
||||||||||||
|
taxes were not created in the past
|
-
|
(252
|
)
|
-
|
||||||||
|
Other
|
28
|
3
|
98
|
|||||||||
|
Income tax expense
|
2,704
|
1,905
|
2,728
|
|||||||||
|
I.
|
Accounting for uncertainty in income taxes
|
| (1) |
On March 15, 2017 Silicom's Board of Directors declared a dividend of US $1.00 per share payable on April 5, 2017 to shareholders of record as of March 27, 2017, and in the aggregate amount of approximately US $7.4 million for 2016.
|
| (2) |
In January 2017, the Company's compensation committee and board of directors, respectively, have approved the grant of a total of 119,925 options and 78,000 RSUs under the Global Share Incentive Plan (2013), of which options and RSUs granted to directors and office holders are subject to the approval of the Annual General Meeting, which is currently scheduled to convene no later than June 2017, as prescribed under the Israeli Companies Law, 1999 and the Company's Amended and Restated Articles of Association.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|